Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001199835-22-000816
Filing Date
2022-12-19
Accepted
2022-12-19 16:12:08
Documents
36
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 PEAK PHARMACEUTICALS, INC. 12/31/2019 10-K pkph123119-10q.htm 10-Q 251691
2 CERTIFICATION pkph123119-ex31_1.htm EX-31.1 17996
3 CERTIFICATION pkph123119-ex31_2.htm EX-31.2 18096
4 CERTIFICATION pkph123119-ex32_1.htm EX-32.1 7291
5 CERTIFICATION pkph123119-ex32_2.htm EX-32.2 7320
  Complete submission text file 0001199835-22-000816.txt   1224313

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pkph-20191231.xml EX-101.INS 111978
7 XBRL SCHEMA FILE pkph-20191231.xsd EX-101.SCH 17034
8 XBRL CALCULATION FILE pkph-20191231_cal.xml EX-101.CAL 17584
9 XBRL DEFINITION FILE pkph-20191231_def.xml EX-101.DEF 34672
10 XBRL LABEL FILE pkph-20191231_lab.xml EX-101.LAB 120514
11 XBRL PRESENTATION FILE pkph-20191231_pre.xml EX-101.PRE 95982
Mailing Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260
Business Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260 480.659.6404
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-53855 | Film No.: 221471203
SIC: 2834 Pharmaceutical Preparations